enGene Holdings Inc. Warrants (ENGNW)
ENGNW Stock Price Chart
Explore enGene Holdings Inc. Warrants interactive price chart. Choose custom timeframes to analyze ENGNW price movements and trends.
ENGNW Company Profile
Discover essential business fundamentals and corporate details for enGene Holdings Inc. Warrants (ENGNW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Feb 2022
Employees
56.00
Website
https://www.engene.comCEO
Ronald H. W. Cooper
Description
EnGene Holdings Inc., through its enGene, Inc. subsidiary, is a clinical-stage biotechnology company dedicated to advancing genetic medicines. These innovative therapies are designed for targeted delivery to mucosal tissues and other bodily organs. Its foremost developmental asset, EG-70 (detalimogene voraplasmid), represents a non-viral immunotherapy. This treatment is specifically aimed at patients with non-muscle invasive bladder cancer, specifically the carcinoma-in-situ (CIS) subtype, who have shown no response to Bacillus Calmette-Guérin (BCG) therapy. Established in 2023, the firm's operations are based in Saint-Laurent, Canada.
ENGNW Financial Timeline
Browse a chronological timeline of enGene Holdings Inc. Warrants corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Sept 2026
EPS estimate is -$0.44.
Earnings released on 15 Jun 2026
EPS came in at -$0.43 surpassing the estimated -$0.47 by +7.76%.
Earnings released on 9 Mar 2026
EPS came in at -$0.44 surpassing the estimated -$0.56 by +21.37%.
Earnings released on 22 Dec 2025
EPS came in at $2.71 surpassing the estimated -$0.57 by +578.04%.
Earnings released on 11 Sept 2025
EPS came in at $0.57 surpassing the estimated -$0.50 by +213.86%.
Earnings released on 12 Jun 2025
EPS came in at -$0.51 falling short of the estimated -$0.50 by -1.75%.
Earnings released on 10 Mar 2025
EPS came in at -$0.48 falling short of the estimated -$0.37 by -31.29%.
Earnings released on 19 Dec 2024
EPS came in at -$0.03 surpassing the estimated -$0.40 by +92.42%, while revenue for the quarter reached $480.00k .
Earnings released on 10 Sept 2024
EPS came in at -$0.32 surpassing the estimated -$0.38 by +14.65%.
Earnings released on 14 Jun 2024
EPS came in at -$0.38 falling short of the estimated -$0.26 by -45.77%.
Earnings released on 12 Mar 2024
EPS came in at -$0.46 falling short of the estimated -$0.42 by -11.26%.
Earnings released on 29 Jan 2024
EPS came in at -$0.34 .
Earnings released on 31 Jul 2023
EPS came in at -$5.22 .
Earnings released on 30 Apr 2023
EPS came in at -$0.33 .
Earnings released on 31 Jan 2023
EPS came in at -$0.47 .
Earnings released on 31 Oct 2022
EPS came in at -$0.47 .
Earnings released on 31 Jul 2022
EPS came in at -$0.43 .
Earnings released on 30 Apr 2022
EPS came in at -$0.23 .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 .
ENGNW Stock Performance
Access detailed ENGNW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
